Tirzepatide CAS 2023788-19-2 API

Khoom siv:

Cov tshuaj Tirzepatide

分子结构式

CAS Nr:

2023788-19-2

Molecular Formula:

C225H348N48O68

Molecular Luj:

4813.45

适应症 Indication:

Obesity, Type ll Diabetes.

Pharmacology:

GIP yog ib qho tshuaj hormones uas tuaj yeem txhawb nqa cov teebmeem ntawm GLP-1 receptor agonists. Hauv cov qauv kev kho mob, GIP tau pom tias txo qis kev noj zaub mov thiab nce kev siv hluav taws xob, yog li ua rau txo qhov hnyav, thiab thaum ua ke nrog GLP-1 receptor agonism, tuaj yeem ua rau muaj kev cuam tshuam ntau dua rau cov cim ntawm metabolic dysregulation xws li lub cev hnyav, qabzib thiab lipids.

给药途径 Route of Administration:

txhaj tshuaj subcutaneous

Taboo:

Tirzepatide tsis haum rau cov neeg mob medullary thyroid cancer

Amino Acid Sequence:

Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-lle-{Aib}Leu-Asp-Lys-lle-Ala-GIn-{diacid-C20- gamma- Glu-(AEEA)2-Lys}-Ala-Phe-Val-GIn-Trp-Leu-lle-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser -NH 2

Solubility:

Soluble hauv dej

纯度:

Ntau dua lossis sib npaug li 99%